Blog
RSS FeedPosted by Michael Wonder on 11 Apr 2024
'Really expensive': migraine expert calls for more funded treatments
10 April 2024 - Migraine experts are advocating for PHARMAC to fund a new generation of migraine drugs that target ...
Posted by Michael Wonder on 10 Apr 2024
Making tender decisions: how does PHARMAC allocate its fixed budget?
10 April 2024 - The annual tender is one of several mechanisms PHARMAC uses to manage how much New Zealand ...
Posted by Michael Wonder on 02 Apr 2024
Cancer experts urge PHARMAC to fast-track 'life-saving' Keytruda
2 April 2024 - Breast cancer experts have urged PHARMAC to fast-track the drug Keytruda, for Kiwis with an aggressive ...
Posted by Michael Wonder on 01 Apr 2024
PHARMAC publishes agenda for May 2024 PTAC meeting
28 March 2024 - Another slim agenda; one cancer medicine. ...
Posted by Michael Wonder on 31 Mar 2024
New Zealand Pharmaceutical Schedule - 1 April 2024
1 April 2024 - The April 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 27 Mar 2024
PHARMAC funds new treatments for breast and blood cancer
27 March 2024 - PHARMAC is funding two new cancer treatments, one for advanced breast cancer (ribociclib succinate) and one ...
Posted by Michael Wonder on 19 Mar 2024
Pharmac initiated lengthy review a waste of valuable time and resources, says Rare Disorders NZ
19 March 2024 - Rare Disorders NZ is very concerned that Pharmac will not extend access to life-saving medicines for ...
Posted by Michael Wonder on 17 Mar 2024
Funding process for child cancer medicines to remain
15 March 2024 - Pharmac has decided to keep Rule 8.1b, which allows medicines for treating children with cancer to ...
Posted by Michael Wonder on 29 Feb 2024
New Zealand Pharmaceutical Schedule - 1 March 2024
1 March 2024 - The March 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 29 Feb 2024
Today is Rare Disease Day
29 February 2024 - PHARMAC understands that people living with rare disorders face many challenges, including access to health care ...
Posted by Michael Wonder on 28 Feb 2024
Minister announces parallel assessment means new medicines assessed sooner
28 February 2024 - PHARMAC is changing its process so it can assess a funding application at the same time Medsafe ...
Posted by Michael Wonder on 22 Feb 2024
Busy dad with leukaemia getting 'outdated treatment'
23 February 2024 - A West Coast dad is receiving “outdated treatment” for his leukaemia because PHARMAC’s policies are blocking ...
Posted by Michael Wonder on 22 Feb 2024
A cancer doctor’s view of why reform of PHARMAC is vital
23 February 2024 - Late last year, many of my colleagues returned from the largest international gathering of doctors who ...
Posted by Michael Wonder on 22 Feb 2024
COVID-19 vaccine available in March
22 February 2024 - Joint media release with Health New Zealand. ...
Posted by Michael Wonder on 15 Feb 2024
More than 30,000 people to benefit under PHARMAC proposal
15 February 2024 - PHARMAC is proposing to fund five treatments to improve the lives of over 30,000 people in New ...